Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression

By He Suqin   Zhang Chaohua   Shafi Ayesha A.   Sequeira Manuel   Acquaviva Jaime   Friedland Julie C.   Sang Jim   Smith Donald L.   Weigel Nancy L.   Wada Yumiko   Proia David A.  

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 35-43

Spandidos Publications

Access to resources Recommend Favorite

Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 47-54

Spandidos Publications

Access to resources Recommend Favorite

Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation

By Zhang Chongyu   Xu Yunze   Chen Dongning   Zhao Juping   Shen Zhoujun   Wu Yuxuan   Zhu Yu  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 4065-4071

Springer Publishing Company

Access to resources Recommend Favorite

Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation

By Machida H.   Matsumoto Y.   Shirai M.   Kubota N.  

International Journal of Radiation Biology, Vol. 79, Iss. 12, 2003-12 ,pp. : 973-980

Informa Healthcare

Access to resources Recommend Favorite

Erratum to: Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation

By Xu Yunze   Zhang Chongyu   Chen Dongning   Zhao Juping   Shen Zhoujun   Wu Yuxuan   Zhu Yu  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 4101-4101

Springer Publishing Company

Access to resources Recommend Favorite